Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2017

01-04-2017 | Gastrointestinal Oncology

Harvest of at Least 23 Lymph Nodes is Indispensable for Stage N3 Gastric Cancer Patients

Authors: Gaozan Zheng, MM, Fan Feng, MD, Man Guo, BMed, Guanghui Xu, MM, Shushang Liu, MM, Zhen Liu, MM, Li Sun, MD, Liu Hong, MD, Jianjun Yang, MD, Xiao Lian, MStat, Daiming Fan, PhD, Hongwei Zhang, PhD

Published in: Annals of Surgical Oncology | Issue 4/2017

Login to get access

Abstract

Background

The National Comprehensive Cancer Network (NCCN) recommends that at least 15 lymph nodes (LNs) be removed during radical gastrectomy. This study aims to investigate the optimal number of LNs resected for radical gastrectomy.

Patients and Methods

From September 2008 to March 2015, a total of 1990 gastric cancer patients were enrolled in this study. Clinicopathological features and survivals were recorded, and the association between the number of LNs resected and the prognosis of gastric cancer were analyzed.

Results

Overall, 1520 males (76.4%) and 470 females (23.6%) were included in the study, with a median age of 57 years (range 20–90). The median number of LNs resected was 24 (range 15–83) for stage N1, 25 (range 15–62) for stage N2, 25 (range 15–88) for stage N3a, and 28 (range 16–73) for stage N3b. The optimal cut-off value for the number of LNs resected was 22 for stage N3a (p = 0.000) and N3b (p = 0.003) patients, while no other cut-off value was significantly superior to 15 for stage N1–2 patients (both p > 0.05). Age, tumor size, tumor depth, and number of LNs resected were independent prognostic predictors for stage N3a patients, while resection type and number of LNs resected were independent prognostic predictors for stage N3b patients. Removing more than 22 LNs exhibited a significant survival benefit compared with removing 15–22 LNs for stage N3a and N3b patients (29.7 vs. 21.6%, p = 0.000; 12.9% vs. 0%, p = 0.003, respectively).

Conclusion

Removing at least 23 LNs could yield better survival outcomes in stage N3 gastric cancer patients.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics: 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics: 2002. CA Cancer J Clin. 2005;55:74–108.CrossRefPubMed
2.
go back to reference Park CH, Song KY, Kim SN. Treatment results for gastric cancer surgery: 12 years’ experience at a single institute in Korea. Eur J Surg Oncol. 2008;34:36–41.CrossRefPubMed Park CH, Song KY, Kim SN. Treatment results for gastric cancer surgery: 12 years’ experience at a single institute in Korea. Eur J Surg Oncol. 2008;34:36–41.CrossRefPubMed
3.
go back to reference Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077–79.CrossRefPubMed Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077–79.CrossRefPubMed
4.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–123.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–123.CrossRef
5.
go back to reference Saito H, Fukumoto Y, Osaki T, Fukuda K, Tatebe S, Tsujitani S, et al. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer. Ann Surg Oncol. 2007;14:1688–93.CrossRefPubMed Saito H, Fukumoto Y, Osaki T, Fukuda K, Tatebe S, Tsujitani S, et al. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer. Ann Surg Oncol. 2007;14:1688–93.CrossRefPubMed
6.
go back to reference Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Lin BJ. Effect of negative lymph node count on survival for gastric cancer after curative distal gastrectomy. Eur J Surg Oncol. 2011;37:481–87.CrossRefPubMed Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Lin BJ. Effect of negative lymph node count on survival for gastric cancer after curative distal gastrectomy. Eur J Surg Oncol. 2011;37:481–87.CrossRefPubMed
7.
go back to reference Baiocchi GL, Tiberio GA, Minicozzi AM, et al. A multicentric western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70–73.CrossRefPubMed Baiocchi GL, Tiberio GA, Minicozzi AM, et al. A multicentric western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg. 2010;252:70–73.CrossRefPubMed
8.
go back to reference Xu D1, Huang Y, Geng Q, et al. Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS ONE. 2012;7:e38681. Xu D1, Huang Y, Geng Q, et al. Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS ONE. 2012;7:e38681.
9.
go back to reference Hirabayashi S, Kosugi S, Isobe Y, et al. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer. Ann Oncol. 2014;25:1179–84.CrossRefPubMed Hirabayashi S, Kosugi S, Isobe Y, et al. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer. Ann Oncol. 2014;25:1179–84.CrossRefPubMed
10.
go back to reference Chen HN, Chen XZ, Zhang WH, et al. Necessity of harvesting at least 25 lymph nodes in patients with stage N2–N3 resectable gastric cancer. Medicine (Baltimore). 2015;94(10):e620.CrossRefPubMedPubMedCentral Chen HN, Chen XZ, Zhang WH, et al. Necessity of harvesting at least 25 lymph nodes in patients with stage N2–N3 resectable gastric cancer. Medicine (Baltimore). 2015;94(10):e620.CrossRefPubMedPubMedCentral
11.
go back to reference Edge SB, Byrd DR, Compton CC. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. Edge SB, Byrd DR, Compton CC. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
12.
go back to reference Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–9.CrossRefPubMed Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–9.CrossRefPubMed
13.
go back to reference Deng JY, Liang H, Sun D, Pan Y, Zhang RP, Wang BG, et al. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer. Eur J Surg Oncol. 2009;35:814–9.CrossRefPubMed Deng JY, Liang H, Sun D, Pan Y, Zhang RP, Wang BG, et al. Outcome in relation to numbers of nodes harvested in lymph node-positive gastric cancer. Eur J Surg Oncol. 2009;35:814–9.CrossRefPubMed
14.
go back to reference Okajima W, Komatsu S, Ichikawa D, et al. Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol. 2016;31(9):1566–71.CrossRefPubMed Okajima W, Komatsu S, Ichikawa D, et al. Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer. J Gastroenterol Hepatol. 2016;31(9):1566–71.CrossRefPubMed
15.
go back to reference Shi RL, Chen Q, Ding JB, Yang Z, Pan G, Jiang D, et al. Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy. Oncotarget. 2016;7(23):35084–91.PubMedPubMedCentral Shi RL, Chen Q, Ding JB, Yang Z, Pan G, Jiang D, et al. Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy. Oncotarget. 2016;7(23):35084–91.PubMedPubMedCentral
16.
go back to reference Chen S, Zhao BW, Li YF, et al. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1101 Patients. PLoS ONE. 2012;7:e49424.CrossRefPubMedPubMedCentral Chen S, Zhao BW, Li YF, et al. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1101 Patients. PLoS ONE. 2012;7:e49424.CrossRefPubMedPubMedCentral
17.
go back to reference Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer. 2002;94:2862–6.CrossRefPubMed Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer. 2002;94:2862–6.CrossRefPubMed
18.
go back to reference Biffi R1, Botteri E, Cenciarelli S, et al. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol. 2011;37:305–11. Biffi R1, Botteri E, Cenciarelli S, et al. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection. Eur J Surg Oncol. 2011;37:305–11.
19.
go back to reference Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114–24.CrossRefPubMed Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114–24.CrossRefPubMed
20.
go back to reference Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2007;14:317–28.CrossRefPubMed Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2007;14:317–28.CrossRefPubMed
21.
go back to reference Zhao LY, Li CC1, Jia LY, et al. Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center. Oncotarget. 2016. doi:10.18632/oncotarget.9714. Zhao LY, Li CC1, Jia LY, et al. Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center. Oncotarget. 2016. doi:10.​18632/​oncotarget.​9714.
22.
go back to reference Kutlu OC, Watchell M, Dissanaike S. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol. 2015;24:84–8.CrossRefPubMed Kutlu OC, Watchell M, Dissanaike S. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol. 2015;24:84–8.CrossRefPubMed
23.
go back to reference Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, et al. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy. Ann Surg. 2012;255:50–8.CrossRefPubMed Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, et al. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy. Ann Surg. 2012;255:50–8.CrossRefPubMed
Metadata
Title
Harvest of at Least 23 Lymph Nodes is Indispensable for Stage N3 Gastric Cancer Patients
Authors
Gaozan Zheng, MM
Fan Feng, MD
Man Guo, BMed
Guanghui Xu, MM
Shushang Liu, MM
Zhen Liu, MM
Li Sun, MD
Liu Hong, MD
Jianjun Yang, MD
Xiao Lian, MStat
Daiming Fan, PhD
Hongwei Zhang, PhD
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 4/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5667-4

Other articles of this Issue 4/2017

Annals of Surgical Oncology 4/2017 Go to the issue